Amgen Inc.
INHIBITORS OF KRAS G12C AND METHODS OF USING THE SAME
Last updated:
Abstract:
Provided herein are methods of using KRAS G12C inhibitors. These methods of using the inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
Status:
Application
Type:
Utility
Filling date:
12 Mar 2020
Issue date:
2 Jul 2020